The role of sialic acid-binding immunoglobulin-like-lectin-1 (siglec-1) in immunology and infectious disease

References

• Crocker PR, Varki A. Siglecs in the immune system. Immunology. 2001;103(2):137–145. doi:10.1046/j.0019-2805.2001.01241.x.
   PubMed Web of Science ®Google Scholar
• Zaccai NR, Maenaka K, Maenaka T, et al. Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure. 2003;11(5):557–567. doi:10.1016/S0969-2126(03)00073-X.
   PubMed Web of Science ®Google Scholar
• Prather RS, Rowland RR, Ewen C, et al. An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus. J Virol. 2013;87(17):9538–9546. doi:10.1128/JVI.00177-13.
   PubMed Web of Science ®Google Scholar
• De Saint Jean A, Lucht F, Bourlet T, Delezay O, QAD Transforming growth factor beta 1 up-regulates CD169 (sia l oadhesin) expression on monocyte-derived dendritic cells: role in HIV sexual transmission. AIDS. 2014;28(16):2375–2380. doi:10.1097/QAD.0000000000000431.
   PubMed Web of Science ®Google Scholar
• Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood. 2001;97(1):288–296. doi:10.1182/blood.v97.1.288.
   PubMed Web of Science ®Google Scholar
• Eakin AJ, Bustard MJ, McGeough CM, Ahmed T, Bjourson AJ, Gibson DS. Siglec-1 and -2 as potential biomarkers in autoimmune disease. Proteomics Clin Appl. 2016;10(6):635–644. doi:10.1002/prca.201500069.
   PubMed Web of Science ®Google Scholar
• Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7(4):255–266. doi:10.1038/nri2056.
   PubMed Web of Science ®Google Scholar
• O’Reilly MK, Paulson JC. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci. 2009;30(5):240–248. doi:10.1016/j.tips.2009.02.005.
   PubMed Web of Science ®Google Scholar
• Wohner M, Born S, Nitschke L. Human CD22 cannot fully substitute murine CD22 functions in vivo, as shown in a new knockin mouse model. Eur J Immunol. 2012;42(11):3009–3018. doi:10.1002/eji.201242629.
   PubMed Web of Science ®Google Scholar
• Bornhöfft KF, Goldammer T, Rebl A, Galuska SP. Siglecs: a journey through the evolution of sialic acid-binding immunoglobulin-type lectins. Dev Comp Immunol. 2018;86:219–231. doi:10.1016/j.dci.2018.05.008.
   PubMed Web of Science ®Google Scholar
• Chang YC, Nizet V. The interplay between Siglecs and sialylated pathogens. Glycobiology. 2014;24(9):818–825. doi:10.1093/glycob/cwu067.
   PubMed Web of Science ®Google Scholar
• van den Berg TK, Nath D, Ziltener HJ, et al. Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J Immunol. 2001;166(6):3637–3640. doi:10.4049/jimmunol.166.6.3637.
   PubMed Web of Science ®Google Scholar
• Wu Y, Lan C, Ren D, Chen GY. Induction of Siglec-1 by endotoxin tolerance suppresses the innate immune response by promoting TGF-β1 production. J Biol Chem. 2016;291(23):12370–12382. doi: 10.1074/jbc.M116.721258.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li R, Qiao S, Chen XX, Deng R, Zhang G. Porcine sialoadhesin suppresses type I interferon production to support porcine reproductive and respiratory syndrome virus infection. Vet Res. 2020;51(1):18. doi:10.1186/s13567-020-00743-7.
   PubMed Web of Science ®Google Scholar
• Jans J, Unger WWJ, Vissers M, et al. Siglec-1 inhibits RSV-induced interferon gamma production by adult T cells in contrast to newborn T cells. Eur J Immunol. 2018;48(4):621–631. doi:10.1002/eji.201747161.
   PubMed Web of Science ®Google Scholar
• Rose T, Grutzkau A, Hirseland H, et al. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 2013;72(10):1639–1645. doi:10.1136/annrheumdis-2012-201586.
   PubMed Web of Science ®Google Scholar
• York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum. 2007;56(3):1010–1020. doi:10.1002/art.22382.
   PubMedGoogle Scholar
• Ferreira RC, Guo H, Coulson RMR, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes. 2014;63(7):2538–2550. doi:10.2337/db13-1777.
   PubMed Web of Science ®Google Scholar
• Xiong Y-S, Cheng Y, Lin Q-S, et al. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatology (Oxford). 2014;53(2):250–259. doi:10.1093/rheumatology/ket342.
   PubMed Web of Science ®Google Scholar
• Clancy RM, Halushka M, Rasmussen SE, Lhakhang T, Chang M, Buyon JP. Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block. J Immunol. 2019;202(1):48–55. doi:10.4049/jimmunol.1800357.
   PubMed Web of Science ®Google Scholar
• Bao G, Han Z, Yan Z, et al. Increased Siglec-1 expression in monocytes of patients with primary biliary cirrhosis. Immunol Invest. 2010;39(6):645–660. doi:10.3109/08820139.2010.485625.
   PubMed Web of Science ®Google Scholar
• Xiong YS, Yu J, Li C, Zhu L, Wu LJ, Zhong RQ. The role of Siglec-1 and SR-BI interaction in the phagocytosis of oxidized low density lipoprotein by macrophages. PLoS One. 2013;8(3):e58831. doi:10.1371/journal.pone.0058831.
   PubMed Web of Science ®Google Scholar
• Xiong Y-s, Zhou Y-h, Rong G-h, et al. Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease. Clin Biochem. 2009;42(10–11):1057–1063. doi:10.1016/j.clinbiochem.2009.02.026.
   PubMed Web of Science ®Google Scholar
• Tanno A, Fujino N, Yamada M, et al. Decreased expression of a phagocytic receptor Siglec-1 on alveolar macrophages in chronic obstructive pulmonary disease. Respir Res. 2020;21(1):30. doi:10.1186/s12931-020-1297-2.
   PubMed Web of Science ®Google Scholar
• Kirchberger S, Majdic O, Steinberger P, et al. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression. J Immunol. 2005;175(2):1145–1152. doi:10.4049/jimmunol.175.2.1145.
   PubMed Web of Science ®Google Scholar
• Puryear WB, Akiyama H, Geer SD, et al. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog. 2013;9(4):e1003291. doi:10.1371/journal.ppat.1003291.
   PubMed Web of Science ®Google Scholar
• Perez-Zsolt D, Erkizia I, Pino M, et al. Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry. Nat Microbiol. 2019;4(9):1558–1570. doi:10.1038/s41564-019-0453-2.
   PubMed Web of Science ®Google Scholar
• Sewald X, Ladinsky MS, Uchil PD, et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science. 2015;350(6260):563–567. doi:10.1126/science.aab2749.
   PubMed Web of Science ®Google Scholar
• Uchil PD, Pi R, Haugh KA, et al. A protective role for the lectin CD169/Siglec-1 against a pathogenic murine retrovirus. Cell Host Microbe. 2019;25(1):87–100.e10. doi:10.1016/j.chom.2018.11.011.
   PubMed Web of Science ®Google Scholar
• Frederico B, Chao B, Lawler C, May JS, Stevenson PG. Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol. 2015;96(8):2314–2327. doi:10.1099/vir.0.000140.
   PubMedGoogle Scholar
• Xie J, Christiaens I, Yang B, et al. Preferential use of Siglec-1 or Siglec-10 by type 1 and type 2 PRRSV strains to infect PK15S1–CD163 and PK15S10–CD163 cells. Vet Res. 2018;49(1):49. doi:10.1186/s13567-018-0569-z.
   PubMedGoogle Scholar
• Heikema A, Bergman MP, Richards H, et al. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni Lipooligosaccharides. Infect Immun. 2010;78(7):3237–3246. doi:10.1128/IAI.01273-09.
   PubMed Web of Science ®Google Scholar
• Lund SJ, Patras KA, Kimmey JM, et al. Developmental immaturity of siglec receptor expression on neonatal alveolar macrophages predisposes to severe group B streptococcal infection. iScience. 2020;23(6):101207. doi:10.1016/j.isci.2020.101207.
   PubMed Web of Science ®Google Scholar
• Jones C, Virji M, Crocker PR. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol. 2003;49(5):1213–1225. doi:10.1046/j.1365-2958.2003.03634.x.
   PubMed Web of Science ®Google Scholar
• Souriant S, Balboa L, Dupont M, et al. Tuberculosis exacerbates HIV-1 infection through IL-10/STAT3-dependent tunneling nanotube formation in macrophages. Cell Rep. 2019;26(13):3586–3599.e7. doi:10.1016/j.celrep.2019.02.091.
   PubMed Web of Science ®Google Scholar
• Monteiro VG, Lobato CS, Silva AR, et al. Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol Res. 2005;97(5):380–385. doi:10.1007/s00436-005-1460-1.
   PubMed Web of Science ®Google Scholar
• Jacobs T, Erdmann H, Fleischer B. Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi. Eur J Cell Biol. 2010;89(1):113–116. doi:10.1016/j.ejcb.2009.10.006.
   PubMed Web of Science ®Google Scholar
• Martinez-Picado J, McLaren PJ, Erkizia I, et al. Identification of Siglec-1 null individuals infected with HIV-1. Nat Commun. 2016;7(1):12412. doi:10.1038/ncomms12412.
   PubMedGoogle Scholar
• Soukup J, Becker S. Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro. Clin Immunol. 2003;107(3):178–185. doi:10.1016/S1521-6616(03)00038-X.
   PubMed Web of Science ®Google Scholar
• Jans J, El Moussaoui H, Groot R, Jonge M, Ferwerda G. Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus. Virol J. 2016;13(1):52. doi:10.1186/s12985-016-0506-6.
   PubMedGoogle Scholar
• Braschi E, Shojania K, Allan GM. Anti-CCP: a truly helpful rheumatoid arthritis test?Can Fam Phys. 2016;62(3):234.
   PubMed Web of Science ®Google Scholar
• Lleo A, Invernizzi P, Mackay I-R, Prince H, Zhong R-Q, Gershwin M-E. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol. 2008;14(21):3328–3337. doi:10.3748/wjg.14.3328.
   PubMed Web of Science ®Google Scholar
• Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit Care. 2011;15(4):R183. doi:10.1186/cc10332.
   PubMed Web of Science ®Google Scholar
• Sundar KM, Sires M. Sepsis induced immunosuppression: Implications for secondary infections and complications. Indian J Crit Care Med. 2013;17(3):162–169. doi:10.4103/0972-5229.117054.
   PubMedGoogle Scholar
• Xiong Y-S, Wu A-L, Mu D, et al. Inhibition of siglec-1 by lentivirus mediated small interfering RNA attenuates atherogenesis in apoE-deficient mice. Clin Immunol. 2017;174:32–40. doi:10.1016/j.clim.2016.11.005.clim.2016.11.005.
   PubMed Web of Science ®Google Scholar
• Xiong Y-s, Wu A-l, Lin Q-s, et al. Contribution of monocytes Siglec-1 in stimulating T cells proliferation and activation in atherosclerosis. Atherosclerosis. 2012;224(1):58–65. doi:10.1016/j.atherosclerosis.2012.06.063.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra043430.
   PubMed Web of Science ®Google Scholar
• Gijbels MJ, van der Cammen M, van der Laan LJ, et al. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis. 1999;143(1):15–25. doi:10.1016/s0021-9150(98)00263-9.
   PubMed Web of Science ®Google Scholar
• Hussell T, Bell T. Alveolar macrophages: Plasticity in a tissue-specific context. Nat Rev Immunol. 2014;14(2):81–93. doi:10.1038/nri3600.
   PubMed Web of Science ®Google Scholar
• Bharat A, Bhorade SM, Morales-Nebreda L, et al. Flow cytometry reveals similarities between lung macrophages in humans and mice. Am J Respir Cell Mol Biol. 2016;54(1):147–149. doi:10.1165/rcmb.2015-0147LE.
   PubMed Web of Science ®Google Scholar
• Yu Y-RA, Hotten DF, Malakhau Y, et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am J Respir Cell Mol Biol. 2016;54(1):13–24. doi:10.1165/rcmb.2015-0146OC.
   PubMed Web of Science ®Google Scholar
• Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006;194(10):1375–1384. doi:10.1086/508428.
   PubMed Web of Science ®Google Scholar
• Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35(5):1039–1047. doi:10.1183/09031936.00036709.
   PubMed Web of Science ®Google Scholar
• Berenson CS, Kruzel RL, Eberhardt E, Sethi S. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease. J Infect Dis. 2013;208(12):2036–2045. doi:10.1093/infdis/jit400.[Mismatch]infdis/.
   PubMed Web of Science ®Google Scholar
• Gern JE, Busse WW. Association of rhinovirus infections with asthma. Clin Microbiol Rev. 1999;12(1):9–18. doi:10.1128/CMR.12.1.9.
   PubMed Web of Science ®Google Scholar
• Shaabani N, Duhan V, Khairnar V, et al. CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection. Cell Death Dis. 2016;7(11):e2446. doi:10.1038/cddis.2016.350.
   PubMed Web of Science ®Google Scholar
• Eloranta ML, Alm GV. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus. Scand J Immunol. 1999;49(4):391–394. doi:10.1046/j.1365-3083.1999.00514.x.
   PubMed Web of Science ®Google Scholar
• Louie DAP, Liao S. Lymph node subcapsular sinus macrophages as the frontline of lymphatic immune defense. Front Immunol. 2019;10:347.
   PubMedGoogle Scholar
• Duhan V, Khairnar V, Friedrich S-K, et al. Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8(+) T-cell priming and viral control. Sci Rep. 2016;6:19191. doi:10.1038/srep19191.
   PubMed Web of Science ®Google Scholar
• Jobe O, Trinh HV, Kim J, et al. Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region. J Leukoc Biol. 2016;99(6):1089–1106. doi:10.1189/jlb.2A0815-361R.
   PubMed Web of Science ®Google Scholar
• Izquierdo-Useros N, Lorizate M, Puertas MC, et al. Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol. 2012;10(12):e1001448. doi:10.1371/journal.pbio.1001448.
   PubMed Web of Science ®Google Scholar
• Puryear WB, Yu X, Ramirez NP, Reinhard BM, Gummuluru S. HIV-1 incorporation of host-cellderived glycosphingolipid GM3 allows for capture by mature dendritic cells. Proc Natl Acad Sci USA. 2012;109(19):7475–7480. doi:10.1073/pnas.1201104109.
   PubMed Web of Science ®Google Scholar
• Shaw GM, Hunter E. HIV transmission. Cold Spring Harb Perspect Med. 2012;2(11):a006965. doi:10.1101/cshperspect.a006965.
   PubMed Web of Science ®Google Scholar
• Yu HJ, Reuter MA, McDonald D. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog. 2008;4(8):e1000134. doi:10.1371/journal.ppat.1000134.
   PubMed Web of Science ®Google Scholar
• McDonald D. Dendritic cells and HIV-1 trans-infection. Viruses. 2010;2(8):1704–1717. doi:10.3390/v2081704.
   PubMed Web of Science ®Google Scholar
• Jobe O, Kim J, Rao M. The role of Siglec-1 in HIV-1/macrophage interaction. Macrophage. 2016;3:e1435.
   PubMedGoogle Scholar
• Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA. 2006;103(3):738–743. doi:10.1073/pnas.0507995103.
   PubMed Web of Science ®Google Scholar
• Ganor Y, Real F, Sennepin A, et al. HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy. Nat Microbiol. 2019;4(4):633–644. doi:10.1038/s41564-018-0335-z.
   PubMed Web of Science ®Google Scholar
• Perez-Zsolt D, Martinez-Picado J, Izquierdo-Useros N. When dendritic cells go viral: the role of Siglec-1 in host defense and dissemination of enveloped viruses. Viruses. 2019;12(1):8. doi:10.3390/v12010008.
   PubMed Web of Science ®Google Scholar
• Rempel H, Calosing C, Sun B, Pulliam L. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One. 2008;3(4):e1967. doi:10.1371/journal.pone.0001967.
   PubMed Web of Science ®Google Scholar
• Zou Z, Chastain A, Moir S, et al. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One. 2011;6(9):e24559. doi:10.1371/journal.pone.0024559.
   PubMed Web of Science ®Google Scholar
• Pino M, Erkizia I, Benet S, et al. HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology. 2015;12(1):37. doi:10.1186/s12977-015-0160-x.
   PubMedGoogle Scholar
• Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365–1371. doi:10.1038/nm1511.
   PubMed Web of Science ®Google Scholar
• Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010;6(8):e1001052. doi:10.1371/journal.ppat.1001052.
   PubMed Web of Science ®Google Scholar
• Hensley-McBain T, Berard AR, Manuzak JA, et al. Intestinal damage precedes mucosal immune dysfunction in SIV infection. Mucosal Immunol. 2018;11(5):1429–1440. doi:10.1038/s41385-018-0032-5.
   PubMed Web of Science ®Google Scholar
• Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest. 2005;115(11):3265–3275. doi:10.1172/JCI26032.
   PubMed Web of Science ®Google Scholar
• Mandl JN, Barry AP, Vanderford TH, et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and non-pathogenic AIDS virus infections. Nat Med. 2008;14(10):1077–1087. doi:10.1038/nm.1871.
   PubMed Web of Science ®Google Scholar
• Perez-Zsolt D, Cantero-Perez J, Erkizia I, et al. Dendritic cells from the cervical mucosa capture and transfer HIV-1 via Siglec-1. Front Immunol. 2019;10:825. doi:10.3389/fimmu.2019.00825.
   PubMed Web of Science ®Google Scholar
• Gautier G, Humbert M, Deauvieau F, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med. 2005;201(9):1435–1446. doi:10.1084/jem.20041964.
   PubMed Web of Science ®Google Scholar
• Gummuluru S, Ramirez NG, Akiyama H. CD169-dependent cell-associated HIV-1 transmission: a driver of virus dissemination. J Infect Dis. 2014;210(Suppl3):S641–S647. doi:10.1093/infdis/jiu442.
   Google Scholar
• Izquierdo-Useros N, Lorizate M, McLaren PJ, Telenti A, Kräusslich H-G, Martinez-Picado J. HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog. 2014;10(7):e1004146. doi:10.1371/journal.ppat.1004146.
   PubMed Web of Science ®Google Scholar
• Kijewski SDG, Akiyama H, Feizpour A, et al. Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated. Virology. 2016;497:328–336. doi:10.1016/j.virol.2016.07.029.
   PubMed Web of Science ®Google Scholar
• Boggiano C, Manel N, Littman DR. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J Virol. 2007;81(5):2519–2523. doi:10.1128/JVI.01661-06.
   PubMed Web of Science ®Google Scholar
• Gummuluru S, Rogel M, Stamatatos L, Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol. 2003;77(23):12865–12874. doi:10.1128/JVI.77.23.12865-12874.2003.
   PubMed Web of Science ®Google Scholar
• Varchetta S, Lusso P, Hudspeth K, et al. Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages. Retrovirology. 2013;10:154. doi:10.1186/1742-4690-10-154
   PubMed Web of Science ®Google Scholar
• Kim W-K, McGary CM, Holder GE, et al. Increased expression of CD169 on blood monocytes and its regulation by virus and CD8 T cells in macaque models of HIV infection and AIDS. AIDS Res Hum Retroviruses. 2015;31(7):696–706. doi:10.1089/AID.2015.0003.
   PubMed Web of Science ®Google Scholar
• Stumptner-Cuvelette P, Morchoisne S, Dugast M, et al. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA. 2001;98(21):12144–12149. doi:10.1073/pnas.221256498.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol. 2003;163(6):2347–2370. doi:10.1016/S0002-9440(10)63591-2
   PubMed Web of Science ®Google Scholar
• Alvarez CP, Lasala F, Carrillo J, Muñiz O, Corbí AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol. 2002;76(13):6841–6844. doi:10.1128/jvi.76.13.6841-6844.2002.
   PubMed Web of Science ®Google Scholar
• Moller-Tank S, Maury W. Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology. 2014;468–470:565–580. doi:10.1016/j.virol.2014.09.009.
   PubMed Web of Science ®Google Scholar
• Gramberg T, Hofmann H, Möller P, et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology. 2005;340(2):224–236. doi:10.1016/j.virol.2005.06.026.
   PubMed Web of Science ®Google Scholar
• Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005;308(5728):1643–1645. doi:10.1126/science.1110656.
   PubMed Web of Science ®Google Scholar
• Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011;477(7364):340–343. doi:10.1038/nature10348.
   PubMed Web of Science ®Google Scholar
• Cote M, Misasi J, Ren T, et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature. 2011;477(7364):344–348. doi:10.1038/nature10380.
   PubMed Web of Science ®Google Scholar
• Delrue I, Van Gorp H, Van Doorsselaere J, Pl D, Hj N. Susceptible cell lines for the production of porcine reproductive and respiratory syndrome virus by stable transfection of sialoadhesin and CD163. BMC Biotechnol. 2010;10:48. doi:10.1186/1472-6750-10-48.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Hou J, Zhou Y, Yang Y, Xie B, Cao X. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 2015;25(10):1121–1136. doi:10.1038/cr.2015.108.
   PubMed Web of Science ®Google Scholar
• Lawler C, Tan CSE, Simas JP, Stevenson PG. Type I interferons and NK cells restrict gammaherpesvirus lymph node infection. J Virol. 2016;90(20):9046–9057. doi:10.1128/JVI.01108-16.
   PubMed Web of Science ®Google Scholar
• Ang CW, Jacobs BC, Laman JD. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 2004;25(2):61–66. doi:10.1016/j.it.2003.12.004.
   PubMed Web of Science ®Google Scholar
• Jacobs BC, van Doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol. 1996;40(2):181–187. doi:10.1002/ana.410400209.
   PubMed Web of Science ®Google Scholar
• Godschalk PC, Kuijf ML, Li J, et al. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect Immun. 2007;75(3):1245–1254. doi:10.1128/IAI.00872-06.
   PubMed Web of Science ®Google Scholar
• Madrid L, Seale AC, Kohli-Lynch M, Infant GBS Disease Investigator Group, et al. Infant Group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160–s72. doi:10.1093/cid/cix656.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Maiden MC. Meningococcal carriage and disease–population biology and evolution. Vaccine. 2009;27(4):B64–B70. doi:10.1016/j.vaccine.2009.04.061
   PubMedGoogle Scholar
• Vogel U, Frosch M. Mechanisms of neisserial serum resistance. Mol Microbiol. 1999;32(6):1133–1139. doi:10.1046/j.1365-2958.1999.01469.x.
   PubMed Web of Science ®Google Scholar
• Esmail H, Riou C, Bruyn ED, et al. The immune response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons. Annu Rev Immunol. 2018;36:603–638. doi:10.1146/annurev-immunol-042617-053420.
   PubMed Web of Science ®Google Scholar
• Bax M, Kuijf ML, Heikema AP, et al. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun. 2011;79(7):2681–2689. doi:10.1128/IAI.00009-11.
   PubMed Web of Science ®Google Scholar
• Avril T, Wagner ER, Willison HJ, Crocker PR. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect Immun. 2006;74(7):4133–4141. doi:10.1128/IAI.02094-05.
   PubMed Web of Science ®Google Scholar
• Pitts SI, Maruthur NM, Langley GE, et al. Obesity, diabetes, and the risk of invasive group B streptococcal disease in nonpregnant adults in the United States. Open Forum Infect Dis. 2018;5(6):ofy030.
   PubMed Web of Science ®Google Scholar
• Dupont M, Souriant S, Balboa L, et al. Tuberculosis-associated IFN-I induces Siglec-1 on tunnelling nanotubes and favors HIV-1 spread in macrophages. Elife. 2020;9:e52535. 52535. doi:10.7554/eLife.
   PubMed Web of Science ®Google Scholar
• Kabaso D, Lokar M, Kralj-Iglič V, Veranič P, Iglič A. Temperature and cholera toxin B are factors that influence formation of membrane nanotubes in RT4 and T24 urothelial cancer cell lines. Int J Nanomedicine. 2011;6:495–509. doi:10.2147/IJN.S16982.
   PubMed Web of Science ®Google Scholar
• Halasz H, Ghadaksaz AR, Madarasz T, et al. Live cell superresolution-structured illumination microscopy imaging analysis of the intercellular transport of microvesicles and costimulatory proteins via nanotubes between immune cells. Methods Appl Fluoresc. 2018;6(4):045005. doi:10.1088/2050-6120/aad57d.
   PubMed Web of Science ®Google Scholar
• Bracq L, Xie M, Benichou S, Bouchet J. Mechanisms for cell-to-cell transmission of HIV-1. Front Immunol. 2018;9:260. doi:10.3389/fimmu.2018.00260.
   PubMedGoogle Scholar
• Brener Z. Biology of Trypanosoma Cruzi. Annu Rev Microbiol. 1973;27(1):347–382. doi:10.1146/annurev.mi.27.100173.002023.
   PubMed Web of Science ®Google Scholar
• Rosestolato CTF, Dutra J. d M F, De Souza W, de Carvalho TMU. Participation of host cell actin filaments during interaction of trypomastigote forms of Trypanosoma cruzi with host cells. Cell Struct Funct. 2002;27(2):91–98. doi:10.1247/csf.27.91.
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Nunes MP, Teixeira MM, Rocha MOC. Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 2012;9(10):576–589. doi:10.1038/nrcardio.2012.109.
   PubMed Web of Science ®Google Scholar
• Buscaglia C, Campo V, Frasch A, Di Noia J. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat Rev Microbiol. 2006;4(3):229–236. doi:10.1038/nrmicro1351.
   PubMed Web of Science ®Google Scholar
• Buschiazzo A, Amaya MF, Cremona ML, Frasch AC, Alzari PM. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol Cell. 2002;10(4):757–768. doi:10.1016/S1097-2765(02)00680-9.
   PubMed Web of Science ®Google Scholar
• Risso MG, Garbarino GB, Mocetti E, et al. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages. J Infect Dis. 2004;189(12):2250–2259. doi:10.1086/420831.
   PubMed Web of Science ®Google Scholar
• Tomlinson S, Pontes de Carvalho LC, Vandekerckhove F, Nussenzweig V. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol. 1994;153(7):3141–3147.
   PubMed Web of Science ®Google Scholar
• Holscher C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immunol. 2004;193(1):1–17. doi:10.1007/s00430-003-0186-x.
   PubMed Web of Science ®Google Scholar
• Erdmann H, Steeg C, Koch-Nolte F, Fleischer B, Jacobs T. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell Microbiol. 2009;11(11):1600–1611. doi:10.1111/j.1462-5822.2009.01350.x.
   PubMed Web of Science ®Google Scholar
• Fontana MF, de Melo GL, Anidi C, et al. Macrophage colony stimulating factor derived from CD4+ T cells contributes to control of a blood-borne infection. PLoS Pathog. 2016;12(12):e1006046. doi:10.1371/journal.ppat.1006046.
   PubMed Web of Science ®Google Scholar
• Gupta P, Lai SM, Sheng J, et al. Tissue-resident CD169(+) macrophages form a crucial front line against plasmodium infection. Cell Rep. 2016;16(6):1749–1761. doi:10.1016/j.celrep.2016.07.010.
   PubMed Web of Science ®Google Scholar
• Chen WC, Kawasaki N, Nycholat CM, et al. Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS One. 2012;7(6):e39039. doi:10.1371/journal.pone.0039039.
   PubMed Web of Science ®Google Scholar
• Edgar LJ, Kawasaki N, Nycholat CM, Paulson JC. Targeted delivery of antigen to activated CD169+ Macrophages Induces Bias for Expansion of CD8+ T Cells. Cell Chem Biol. 2019;26(1):131–136.e4. doi:10.1016/j.chembiol.2018.10.006.
   PubMed Web of Science ®Google Scholar
• Veninga H, Borg EG, Vreeman K, et al. Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses. Eur J Immunol. 2015;45(3):747–757. doi:10.1002/eji.201444983.
   PubMed Web of Science ®Google Scholar
• Kawasaki N, Vela JL, Nycholat CM, et al. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc Natl Acad Sci USA. 2013;110(19):7826–7831. doi:10.1073/pnas.1219888110.
   PubMed Web of Science ®Google Scholar
• van Dinther D, Veninga H, Revet M, et al. Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma. Front Immunol. 2018;9:1997. doi:10.3389/fimmu.2018.01997.
   PubMed Web of Science ®Google Scholar
• van Dinther D, Lopez Venegas M, Veninga H, in mice and humans, et al. Activation of CD8+ T cell responses after melanoma antigen targeting to CD169+ antigen presenting cells. Cancers. 2019;11(2):183. doi:10.3390/cancers11020183.
   PubMed Web of Science ®Google Scholar
• Park SM, Angel CE, McIntosh JD, et al. Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes. PLoS One. 2014;9(4):e94781. doi:10.1371/journal.pone.0094781.
   PubMed Web of Science ®Google Scholar
• Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606–616. doi:10.1038/nri1669.
   PubMed Web of Science ®Google Scholar
• Steiniger BS. Human spleen microanatomy: why mice do not suffice. Immunology. 2015;145(3):334–346. doi:10.1111/imm.12469.
   PubMed Web of Science ®Google Scholar
• Steiniger B, Barth P, Herbst B, Hartnell A, Crocker PR. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology. 1997;92(2):307–316. doi:10.1046/j.1365-2567.1997.00328.x.
   PubMed Web of Science ®Google Scholar
• Steiniger BS, Seiler A, Lampp K, Wilhelmi V, Stachniss V. Blymphocyte compartments in the human splenic red pulp: capillary sheaths and periarteriolar regions. Histochem Cell Biol. 2014;141(5):507–518. doi:10.1007/s00418-013-1172-z.
   PubMed Web of Science ®Google Scholar
• Delputte PL, Van Gorp H, Favoreel HW, et al. Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS One. 2011;6(2):e16827. doi:10.1371/journal.pone.0016827.
   PubMed Web of Science ®Google Scholar
• Poderoso T, Martinez P, Alvarez B, et al. Delivery of antigen to sialoadhesin or CD163 improves the specific immune response in pigs. Vaccine. 2011;29(29–30):4813–4820. doi:10.1016/j.vaccine.2011.04.076.
   PubMed Web of Science ®Google Scholar
• Aarnoudse CA, Bax M, Sanchez-Hernandez M, Garcia-Vallejo JJ, van Kooyk Y. Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. Int J Cancer. 2008;122(4):839–846. doi:10.1002/ijc.23101.
   PubMed Web of Science ®Google Scholar
• Singh SK, Stephani J, Schaefer M, et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol. 2009;47(2–3):164–174. doi:10.1016/j.molimm.2009.09.026.
   PubMed Web of Science ®Google Scholar
• Taylor ME, Drickamer K. Structural insights into what glycan arrays tell us about how glycan-binding proteins interact with their ligands. Glycobiology. 2009;19(11):1155–1162. doi:10.1093/glycob/cwp076.
   PubMed Web of Science ®Google Scholar
• Graham SA, Jegouzo SA, Yan S, et al. Prolectin, a glycan-binding receptor on dividing B cells in germinal centers. J Biol Chem. 2009;284(27):18537–18544. doi:10.1074/jbc.M109.012807.
   PubMed Web of Science ®Google Scholar
• Zajonc DM, Kronenberg M. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells. Immunol Rev. 2009;230(1):188–200. doi:10.1111/j.1600-065X.2009.00802.x.
   PubMedGoogle Scholar
• Barral P, Polzella P, Bruckbauer A, et al. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol. 2010;11(4):303–312. doi:10.1038/ni.1853.
   PubMed Web of Science ®Google Scholar
• Barral P, Sanchez-Nino MD, van Rooijen N, Cerundolo V, Batista FD. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. Embo J. 2012;31(10):2378–2390. doi:10.1038/emboj.2012.87.
   PubMed Web of Science ®Google Scholar
• Le Bon A, Thompson C, Kamphuis E, et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol. 2006;176(4):2074–2078. doi:10.4049/jimmunol.176.4.2074.
   PubMed Web of Science ®Google Scholar
• Fink K, Lang KS, Manjarrez-Orduno N, et al. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur J Immunol. 2006;36(8):2094–2105. doi:10.1002/eji.200635993.
   PubMed Web of Science ®Google Scholar
• Phan TG, Green JA, Gray EE, Xu Y, Cyster JG. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol. 2009;10(7):786–793. doi:10.1038/ni.1745.
   PubMed Web of Science ®Google Scholar
• Sawyer JD, Wilson ML, Neumeister MW. A systematic review of surgical management of melanoma of the external ear. Plast Reconstr Surg Glob Open. 2018;6(4):e1755. doi:10.1097/GOX.0000000000001755.
   PubMedGoogle Scholar
• Allen PJ, Coit DG. The surgical management of metastatic melanoma. Ann Surg Oncol. 2002;9(8):762–770. doi:10.1007/BF02574498.
   PubMed Web of Science ®Google Scholar
• Berney C, Herren S, Power CA, Gordon S, Martinez-Pomares L, Kosco-Vilbois MH. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J Exp Med. 1999;190(6):851–860. doi:10.1084/jem.190.6.851.
   PubMed Web of Science ®Google Scholar
• Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007;27(1):160–171. doi:10.1016/j.immuni.2007.06.007.
   PubMed Web of Science ®Google Scholar
• Junt T, Moseman EA, Iannacone M, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007;450(7166):110–114. doi:10.1038/nature06287.
   PubMed Web of Science ®Google Scholar
• Phan T, Grigorova I, Okada T, Cyster J. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8(9):992–1000. doi:10.1038/ni1494.
   PubMed Web of Science ®Google Scholar
• Dobry AS, Zogg CK, Hodi FS, Smith TR, Ott PA, Iorgulescu JB. Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies. Cancer Immunol Immunother. 2018;67(12):1833–1844. doi:10.1007/s00262-018-2241-x.
   PubMed Web of Science ®Google Scholar
• Iorgulescu JB, Harary M, Zogg CK, Ligon KL, et al. Improved risk-adjusted survival for melanoma brain metastases in the era of checkpoint blockade immunotherapies: results from a national cohort. Cancer Immunol Res. 2018;6(9):1039–1045. doi:10.1158/2326-6066.CIR-18-0067.
   PubMed Web of Science ®Google Scholar
• Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–2454. doi:10.1056/NEJMoa1200690.
   PubMed Web of Science ®Google Scholar
• Tumeh PC, Harview CL, Yearley JH, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–571. doi:10.1038/nature13954.
   PubMed Web of Science ®Google Scholar
• Daud AI, Loo K, Pauli ML, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126(9):3447–3452. doi:10.1172/JCI87324.
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541–550. doi:10.1038/s41591-018-0014-x.
   PubMed Web of Science ®Google Scholar
• Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74–80. doi:10.1126/science.aaa6204.
   PubMed Web of Science ®Google Scholar
• Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat Rev Immunol. 2016;16(2):102–111. doi:10.1038/nri.2015.10.
   PubMed Web of Science ®Google Scholar
• Leon B, Ballesteros-Tato A, Randall TD, Lund FE. Prolonged antigen presentation by immune complex-binding dendritic cells programs the proliferative capacity of memory CD8 T cells. J Exp Med. 2014;211(8):1637–1655. doi:10.1084/jem.20131692.
   PubMed Web of Science ®Google Scholar
• Klebanoff CA, Gattinoni L, Palmer DC, et al. Determinants of successful CD8+ T-cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res. 2011;17(16):5343–5352. doi:10.1158/1078-0432.CCR-11-0503.
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Yang JC, Sherry RM, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin Cancer Res. 2011;17(13):4550–4557. doi:10.1158/1078-0432.CCR-11-0116.
   PubMed Web of Science ®Google Scholar
• van Duikeren S, Arens R. Predicting the efficacy of cancer vaccines by evaluating T-cell responses. Oncoimmunology. 2013;2(1):e22616. doi:10.4161/onci.22616.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Klebanoff CA, Restifo NP. Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer. 2012;12(10):671–684. doi:10.1038/nrc3322.
   PubMed Web of Science ®Google Scholar
• Enamorado M, Iborra S, Priego E, et al. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells. Nat Commun. 2017;8:16073. doi:10.1038/ncomms16073.
   PubMed Web of Science ®Google Scholar
• Jacquelot N, Enot DP, Flament C, et al. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. J Clin Invest. 2016;126(3):921–937. doi:10.1172/JCI80071.
   PubMed Web of Science ®Google Scholar
• Hailemichael Y, Dai Z, Jaffarzad N, et al. Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465–472. doi:10.1038/nm.3105.
   PubMed Web of Science ®Google Scholar
• Overwijk WW. Cancer vaccines in the era of checkpoint blockade: the magic is in the adjuvant. Curr Opin Immunol. 2017;47:103–109. doi:10.1016/j.coi.2017.07.015.
   PubMed Web of Science ®Google Scholar
• Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003;421(6925):852–856. doi:10.1038/nature01441.
   PubMed Web of Science ®Google Scholar
• Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300(5617):337–339. doi:10.1126/science.1082305.
   PubMed Web of Science ®Google Scholar
• Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300(5617):339–342. doi:10.1126/science.1083317.
   PubMed Web of Science ®Google Scholar
• Backer R, Schwandt T, Greuter M, et al. Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci USA. 2010;107(1):216–221. doi:10.1073/pnas.0909541107.
   PubMed Web of Science ®Google Scholar
• van Dinther D, Veninga H, Iborra S, et al. Functional CD169 on macrophages mediates interaction with dendritic cells for CD8+ T cell cross-priming. Cell Rep. 2018;22(6):1484–1495. doi:10.1016/j.celrep.2018.01.021.
   PubMed Web of Science ®Google Scholar
• Eickhoff S, Brewitz A, Gerner MY, et al. Robust anti-viral immunity requires multiple distinct T cell-dendritic cell interactions. Cell. 2015;162(6):1322–1337. doi:10.1016/j.cell.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Hor JL, Whitney PG, Zaid A, Brooks AG, Heath WR, Mueller SN. Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4+ and CD8+ T cell activation to localized viral infection. Immunity. 2015;43(3):554–565. doi:10.1016/j.immuni.2015.07.020.
   PubMed Web of Science ®Google Scholar
• Sheng J, Chen Q, Soncin I, Ng SL, Karjalainen K, Ruedl C. A discrete subset of monocyte-derived cells among typical conventional type 2 dendritic cells can efficiently cross-present. Cell Rep. 2017;21(5):1203–1214. doi:10.1016/j.celrep.2017.10.024.
   PubMed Web of Science ®Google Scholar
• Crocker PR, Kelm S, Dubois C, et al. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. Embo J. 1991;10(7):1661–1669.
   PubMed Web of Science ®Google Scholar
• Collins BE, Kiso M, Hasegawa A, et al. Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem. 1997;272(27):16889–16895. doi:10.1074/jbc.272.27.16889.
   PubMed Web of Science ®Google Scholar
• May AP, Robinson RC, Vinson M, Crocker PR, Jones EY. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3’ sialyllactose at 1.85 A resolution. Mol Cell. 1998;1(5):719–728. doi:10.1016/S1097-2765(00)80071-4.
   PubMed Web of Science ®Google Scholar
• Crocker PR, Vinson M, Kelm S, Drickamer K. Molecular analysis of sialoside binding to sialoadhesin by NMR and site-directed mutagenesis. Biochem J. 1999;341(2):355–361. doi:10.1042/0264-6021:3410355.
   PubMedGoogle Scholar
• Kelm S, Brossmer R, Isecke R, Gross HJ, Strenge K, Schauer R. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem. 1998;255(3):663–672. doi:10.1046/j.1432-1327.1998.2550663.x.
   PubMedGoogle Scholar
• Zaccai NR, May AP, Robinson RC, et al. Crystallographic and in silico analysis of the sialoside-binding characteristics of the Siglec sialoadhesin. J Mol Biol. 2007;365(5):1469–1479. doi:10.1016/j.jmb.2006.10.084.
   PubMed Web of Science ®Google Scholar
• Bukrinsky JT, St Hilaire PM, Meldal M, Crocker PR, Henriksen A. Complex of sialoadhesin with a glycopeptide ligand. Biochim Biophys Acta. 2004;1702(2):173–179. doi:10.1016/j.bbapap.2004.08.015.
   PubMed Web of Science ®Google Scholar